Drägerwerk AG & Co. KGaA (DGWPF) Stock Price, News & Analysis

Company Overview

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.

Key Stats

• Today's Range: $46.38 to $46.38
• 50-Day Range: $46.38 to $46.43
• 52-Week Range: $46.38 to $48.42
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: 8.42
• Dividend Yield: 1.06%
• Price Target: N/A
• Consensus Rating: N/A

Drägerwerk AG & Co. KGaA Stock Analysis - MarketRank™

Drägerwerk AG & Co. KGaA scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Drägerwerk AG & Co. KGaA.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Drägerwerk AG & Co. KGaA is 8.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.83.

Price to Earnings Ratio vs. Sector

The P/E ratio of Drägerwerk AG & Co. KGaA is 8.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 109.53.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Drägerwerk AG & Co. KGaA has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Drägerwerk AG & Co. KGaA has recently decreased by 50.00%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Drägerwerk AG & Co. KGaA pays a meaningful dividend of 1.06%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Drägerwerk AG & Co. KGaA does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Drägerwerk AG & Co. KGaA has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Drägerwerk AG & Co. KGaA has recently decreased by 50.00%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Drägerwerk AG & Co. KGaA has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Drägerwerk AG & Co. KGaA this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Drägerwerk AG & Co. KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 13.86% of the stock of Drägerwerk AG & Co. KGaA is held by institutions.

DGWPF Stock Analysis - Frequently Asked Questions

How have DGWPF shares performed this year?

Drägerwerk AG & Co. KGaA's stock was trading at $51.00 at the beginning of the year. Since then, DGWPF shares have decreased by 9.1% and is now trading at $46.3783.
View the best growth stocks for 2024 here.

How do I buy shares of Drägerwerk AG & Co. KGaA?

Shares of DGWPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DGWPF
• CUSIP: N/A
• CIK: N/A
• Web: www.draeger.com
• Phone: 494518820
• Fax: N/A
• Employees: 16,476
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 8.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A